VETRO, CALOGERO
 Distribuzione geografica
Continente #
NA - Nord America 552
EU - Europa 239
AS - Asia 122
AF - Africa 75
OC - Oceania 3
Totale 991
Nazione #
US - Stati Uniti d'America 543
IT - Italia 132
SG - Singapore 73
IE - Irlanda 59
CI - Costa d'Avorio 56
CN - Cina 38
UA - Ucraina 17
SN - Senegal 15
CA - Canada 7
DE - Germania 7
FI - Finlandia 5
BE - Belgio 4
CZ - Repubblica Ceca 4
NG - Nigeria 4
VN - Vietnam 4
AU - Australia 3
CH - Svizzera 2
FR - Francia 2
GB - Regno Unito 2
GR - Grecia 2
HK - Hong Kong 2
IN - India 2
MX - Messico 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
UZ - Uzbekistan 1
Totale 991
Città #
Houston 163
Chicago 76
Singapore 62
Chandler 57
Dublin 57
Abidjan 56
Civitanova Marche 35
Santa Clara 33
Ashburn 32
Boardman 28
Rome 18
Dakar 15
Cambridge 12
Lawrence 12
Jacksonville 10
Andover 8
Catania 8
Los Angeles 8
Falls Church 6
Milan 5
Palermo 5
Piazzola Sul Brenta 5
Wilmington 5
Abuja 4
Brussels 4
Dong Ket 4
Nanjing 4
Toronto 4
Brno 3
Des Moines 3
Helsinki 3
Lamezia Terme 3
Melbourne 3
Munich 3
Seattle 3
Cernusco sul Naviglio 2
Hong Kong 2
Jiaxing 2
Lappeenranta 2
Melilli 2
Misterbianco 2
Nanchang 2
Trecastagni 2
Veracruz 2
Washington 2
Augusta 1
Beijing 1
Bremen 1
Changsha 1
Cosenza 1
Easton 1
Edinburgh 1
Frankfurt am Main 1
Gosport 1
Hanover 1
Hyderabad 1
Kherson 1
Kunming 1
Lentini 1
Ludwigshafen 1
Mascalucia 1
Messina 1
Mumbai 1
Naples 1
Olomouc 1
Ottawa 1
Pace del Mela 1
Perpignan 1
San Francisco 1
San Mateo 1
Santa Venerina 1
Shenyang 1
Tianjin 1
Tremestieri Etneo 1
Woodbridge 1
Totale 807
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 217
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 70
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 57
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 56
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 51
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 48
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 48
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 46
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 45
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 43
VEXAS-like syndrome: a potential new entity? 42
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 39
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 33
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 32
A case of high-risk AML in a patient with advanced systemic mastocytosis 31
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 30
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 30
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 27
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 22
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 17
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature 13
Advances in understanding regulatory myeloid cells 12
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients 9
Totale 1.018
Categoria #
all - tutte 4.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 37 14 4 0 1 0 2 1
2020/202123 0 2 2 2 7 0 2 0 1 0 2 5
2021/2022102 4 5 0 0 14 7 14 3 10 14 5 26
2022/2023218 14 20 10 14 11 23 7 43 53 3 12 8
2023/2024236 10 39 10 21 5 51 18 19 3 8 36 16
2024/2025251 7 121 27 59 37 0 0 0 0 0 0 0
Totale 1.018